CTS Q3 2026 diluted EPS rises 33% to $0.61

By Public Technologies
  • CTS third-quarter 2026 diluted EPS rose 33% year over year to $0.61.
  • Sales increased 5% year over year to $149.6 million, driven by strength across its increasingly diversified portfolio.
  • Operating cash flow jumped 50% year over year to $43.5 million.
  • The Millar acquisition advanced diversification, particularly in the medical end market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTS Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-432724), on October 27, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk